All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @madisonsecretlibrary on TikTok · 35s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @madisonsecretlibrary's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:13Bye!

Can Zepbound costs really be a tax deduction? We checked

madisonsecretlibrary

TikTok creator

244.4K viewsWatch on TikTok

Quick answer

Tirzepatide (Zepbound) is a dual GLP-1/GIP receptor agonist FDA-approved for weight management. In the SURMOUNT-1 trial, 15mg tirzepatide led to 22.5% average weight loss over 72 weeks. Monthly costs range from $1,060 without insurance to $25-550 with manufacturer savings programs.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded TirzepatideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Tirzepatide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Can Zepbound costs really be a tax deduction? We checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Tirzepatide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this tirzepatide video claims cluster

Best for searchers deciding whether tirzepatide claims are stronger, safer, or more relevant than semaglutide claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Can Zepbound costs really be a tax deduction? We checked" from madisonsecretlibrary. We read the clip as a GLP-1 social video fact-checks claim about Compounded Tirzepatide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Tirzepatide (Zepbound) is a dual GLP-1/GIP receptor agonist FDA-approved for weight management.

The reason this review is not generic is the source wording and the canonical claim label "glp1 get that money zepbound taxseason money." In this clip, the useful excerpt is: "Bye!" That wording changes the review because it points to Compounded Tirzepatide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Tirzepatide Once Weekly for the Treatment of Obesity (2022), Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (2024), and Tirzepatide for Obesity Treatment and Diabetes Prevention (2025), plus the creator's own wording. Compounded Tirzepatide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Zepbound costs approximately $12,720 annually without insurance coverage
People who land here are usually comparing the Compounded Tirzepatide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Tirzepatide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Tirzepatide (Zepbound) is a dual GLP-1/GIP receptor agonist FDA-approved for weight management.

FormBlends verdict

Compounded Tirzepatide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Tirzepatide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Tirzepatide (Zepbound) is a dual GLP-1/GIP receptor agonist FDA-approved for weight management. In the SURMOUNT-1 trial, 15mg tirzepatide led to 22.5% average weight loss over 72 weeks. Monthly costs range from $1,060 without insurance to $25-550 with manufacturer savings programs.
  • Prescription drug deductions only apply when total medical costs exceed 7.5% of your adjusted gross income
  • Zepbound costs approximately $12,720 annually without insurance coverage

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Tirzepatide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Tirzepatide guide, cost path, safety notes, and provider review before acting.

Review Compounded Tirzepatide

What You'll Learn

  • Prescription drug deductions only apply when total medical costs exceed 7.5% of your adjusted gross income
  • Zepbound costs approximately $12,720 annually without insurance coverage
  • HSA contributions max at $4,300 annually for individuals in 2024, covering less than half of Zepbound's cost
  • Tirzepatide 15mg produced 22.5% average weight loss in the 72-week SURMOUNT-1 trial
  • Manufacturer savings cards can reduce costs to $25-550 monthly for eligible patients
  • Tax deductions provide partial savings based on your tax bracket, not full refunds
  • Most insurance plans don't cover GLP-1 medications prescribed specifically for weight loss

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this video actually claim?

@madisonsecretlibrary's TikTok suggests that Zepbound costs can be claimed as tax deductions or somehow generate money during tax season. The video's caption combines #zepbound with #taxseason and #money, implying a financial benefit.

The creator doesn't spell out exactly how this works, but the implication is clear: you can get money back on your Zepbound expenses. This kind of content has exploded on TikTok as GLP-1 medications like tirzepatide (Zepbound) cost $1,000+ monthly without insurance.

The video has racked up 244,400 views, suggesting people are hungry for ways to offset these costs.

Can you actually deduct prescription drug costs?

Yes, but there's a massive catch that the video doesn't mention. Prescription medications only qualify as tax-deductible medical expenses if your total medical costs exceed 7.5% of your adjusted gross income (AGI).

For someone making $60,000 annually, medical expenses would need to top $4,500 before any deduction kicks in. Even with Zepbound's $12,000+ annual cost, you'd only deduct the amount above that threshold.

The creator makes this sound like automatic money back. It's not. Most people never hit the 7.5% AGI threshold, making this advice useless for the majority of viewers.

What about Health Savings Accounts?

HSAs offer a better path than standard deductions, but again, it's not as simple as the video suggests. You can use HSA funds for prescription medications like Zepbound without the 7.5% AGI limitation.

However, you need a qualifying high-deductible health plan to contribute to an HSA. The 2024 contribution limit is $4,300 for individuals, which covers less than half of Zepbound's annual cost.

FSAs work similarly but with even lower contribution limits ($3,200 for 2024) and use-it-or-lose-it rules. These accounts help, but they're not the financial windfall the video implies.

What's the real cost situation with Zepbound?

Zepbound (tirzepatide) costs roughly $1,060 monthly without insurance. That's $12,720 annually for a medication that showed 22.5% average weight loss in the SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022).

Eli Lilly offers a savings card that can reduce costs to $25-550 monthly for eligible patients, but this excludes government insurance plans. Most insurance plans don't cover Zepbound for weight loss, though some cover Mounjaro (same drug) for diabetes.

The financial reality is harsh: most people pay full price. Tax strategies help some people, but they're not the easy money-maker this video suggests.

What should you know about GLP-1 medication costs?

Don't count on tax deductions to make these medications affordable. The 7.5% AGI threshold eliminates most people from meaningful deductions, and the video oversells this strategy.

Better options include manufacturer savings programs, patient assistance programs, or shopping compounding pharmacies (though quality varies). Some telehealth platforms negotiate lower prices, though you'll still pay hundreds monthly.

If you're considering Zepbound, budget for $500-1,000 monthly out of pocket. The medication works (15mg tirzepatide produced 22.5% weight loss versus 2.4% for placebo in SURMOUNT-1), but the costs are real and ongoing.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

madisonsecretlibrary · TikTok creator

244.4K views on this video

Get that money!! #zepbound #taxseason #money

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about prescription drug deductions only apply?

Prescription drug deductions only apply when total medical costs exceed 7.5% of your adjusted gross income

What does the video say about zepbound costs approximately $12,720 annually without insurance coverage?

Zepbound costs approximately $12,720 annually without insurance coverage

What does the video say about hsa contributions max at $4,300 annually for individuals in 2024,?

HSA contributions max at $4,300 annually for individuals in 2024, covering less than half of Zepbound's cost

What does the video say about tirzepatide 15mg produced 22.5% average weight loss in the 72-week?

Tirzepatide 15mg produced 22.5% average weight loss in the 72-week SURMOUNT-1 trial

What does the video say about manufacturer savings cards can reduce costs to $25-550 monthly for?

Manufacturer savings cards can reduce costs to $25-550 monthly for eligible patients

What does the video say about tax deductions provide partial savings based on your tax bracket,?

Tax deductions provide partial savings based on your tax bracket, not full refunds

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by madisonsecretlibrary, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.